Article info

Download PDFPDF
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Authors

  1. Correspondence to Dr Michael Bonelli, Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; michael.bonelli{at}meduniwien.ac.at
View Full Text

Citation

Kartnig F, Mrak D, Simader E, et al
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Publication history

  • Received April 20, 2022
  • Accepted September 1, 2022
  • First published September 15, 2022.
Online issue publication 
May 25, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.